| Current dividend yield | 2.88 % |
| Dividendenrendite 5 Jahre | 9.53 % |
| Dividend Yield 10Y | 3.29 % |
| Payout 3Y | 8.35 % |
The Pharmanutra stock dividend is paid once a year. In order to receive a dividend, you should generally own the Pharmanutra stock before the ex-dividend date. The Dividend Calendar shows that the ex-day date was last at May . The dividend from Pharmanutra was paid in May.
| Year | Dividend | Ex-day & Payday |
Frequency | |
|---|---|---|---|---|
| Fiscal Year | Dividend per Share | Ex-Day | Payday | Payment frequency |
| 2026 |
€1.2
€1.2
|
May 04 2026
May 04 2026
May 06 2026
May 04 26
May 06 26 |
May 06 2026 |
annual
yearly
|
| 2025 |
€1
€1
|
May 05 2025
May 05 2025
May 07 2025
May 05 25
May 07 25 |
May 07 2025 |
annual
yearly
|
| 2024 |
€0.85
€0.85
|
May 06 2024
May 06 2024
May 08 2024
May 06 24
May 08 24 |
May 08 2024 |
annual
yearly
|
| 2023 |
€0.8
€0.8
|
May 08 2023
May 08 2023
May 10 2023
May 08 23
May 10 23 |
May 10 2023 |
annual
yearly
|
| 2022 |
€0.71
€0.71
|
May 02 2022
May 02 2022
May 04 2022
May 02 22
May 04 22 |
May 04 2022 |
annual
yearly
|
| 2021 |
€0.67
€0.67
|
May 03 2021
May 03 2021
May 05 2021
May 03 21
May 05 21 |
May 05 2021 |
annual
yearly
|
| 2020 |
€0.46
€0.46
|
May 11 2020
May 11 2020
May 13 2020
May 11 20
May 13 20 |
May 13 2020 |
annual
yearly
|
| 2019 |
€0.42
€0.42
|
May 06 2019
May 06 2019
May 08 2019
May 06 19
May 08 19 |
May 08 2019 |
annual
yearly
|
| 2019 |
€0.08
€0.08
|
May 06 2019
May 06 2019
May 08 2019
May 06 19
May 08 19 |
May 08 2019 |
Special dividend
Special div.
|
| 2018 |
€0.3285
€0.33
|
May 07 2018
May 07 2018
May 09 2018
May 07 18
May 09 18 |
May 09 2018 |
annual
yearly
|
Pharmanutra paid a Dividend of €1.20 Per Share in the financial year 2026. With a stock price of €70.90 at Sep 24 2026, the current dividend yield is 1.69% (calculation: €1.20 / €70.90 = 1.69%). No special dividend was paid.
The average Pharmanutra dividend yield over the last 5 years is 1.53% and the average over the last 10 years is 1.49%.
The payout ratio of Pharmanutra in relation to the last financial year is 47.85%. The payout ratio smoothed over 3 years is 51.46%. The calculation is based on the sum of all dividend payments divided by the cumulative earnings per share(EPS).
| Metric | Pharmanutra |
|---|---|
| Current dividend yield | 1.69% |
| Dividend Yield 5Y | 1.53% |
| Dividend Yield 10Y | 1.49% |
| Payout 1Y | 47.85% |
| Payout 3Y | 51.46% |
Pharmanutra has been paying a dividend for 9 years and has not lowered the dividend for 9 years (dividend continuity). As a result, the dividend was recently increased 9-times.
The Dividend Growth in relation to the previous financial year amounts to 20.00%. The average Pharmanutra Dividend Growth over the last 5 years is 12.36%.
| Metric | Pharmanutra |
|---|---|
| Increased | 9 Years |
| Continuity | 9 Years |
| Paid | 9 Years |
| Growth 1Y | 20.00% |
| Growth 5Y | 12.36% |
Pharmanutra has been paying a dividend for 9 years and has not lowered the dividend for 9 years (dividend continuity). As a result, the dividend was recently increased 9-times.
The Dividend Growth in relation to the previous financial year amounts to 20.00%. The average Pharmanutra Dividend Growth over the last 5 years is 12.36%.
On the stock exchange, the Pharmanutra stock (ISIN: IT0005274094) is not traded as a top scorer in September 2026 according to the dividend strategy.
The stock price of Pharmanutra 30.57% has risen since the beginning of the year 2026. However, the return generated in the past says nothing about the future return. You can find the Pharmanutra stock price in real time at the top of the page.
Pharmanutra (symbol: PHN) is valued at a Price / Earnings Ratio (P/E ratio) of 24.03 and a price/sales ratio (P/S ratio) of 3.49 valued. Based on analyst estimates, the Pharmanutra stock forecast 2026 of the current financial year corresponds to a valuation of 27.92 according to P/E ratio and 4.40 according to P/S.
| Metric | Pharmanutra |
|---|---|
| Dividend Score | ??/15 |
| Performance 2026 |
30.57%
|
| P/E TTM | 24.03 |
| P/S TTM | 3.49 |
| P/E forward | 27.92 |
| P/S forward | 4.40 |
Pharmanutra (symbol: PHN) is valued at a Price / Earnings Ratio (P/E ratio) of 24.03 and a price/sales ratio (P/S ratio) of 3.49 valued. Based on analyst estimates, the Pharmanutra stock forecast 2026 of the current financial year corresponds to a valuation of 27.92 according to P/E ratio and 4.40 according to P/S.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


